Publicações

Patient (Pt) Preference and Satisfaction with the Subcutaneous Fixed-Dose Combination of Pertuzumab (P) and Trastuzumab (H) in Pts with Her2-Positive Early Breast Cancer (Her2+Ebc): Interim Analysis of the Open-Label, Randomised Cross-Over Phrancesca Study

AuthID
P-00S-AAC

Author(s)

O'Shaughnessy, J

Sousa, SP

Cruz, J

Fallowfield, LJ

Auvinen, P

Pulido, C

Cvetanovic, A

Wilks, S

Ribeiro, L

Burotto, M

Klingbiel, D

Messeri, D

Alexandrou, A

Trask, P

Fredriksson, J

Stamatovic, L

Tipo de Documento

Abstract

Year published

2020

Publicado

in ANNALS OF ONCOLOGY, ISSN: 0923-7534

Volume: 31, Páginas: S42-S42 (1)

Conference

Esmo Breast Cancer Virtual Meeting, Date: MAY 23-24, 2020, Location: ELECTR NETWORK, Patrocinadores: European Soc Med Oncol

Indexing

Wos^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/j.annonc.2020.03.020

Wos: WOS:000538879300072

Source Identifiers

ISSN: 0923-7534

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Patient (Pt) Preference and Satisfaction with the Subcutaneous Fixed-Dose Combination of Pertuzumab (P) and Trastuzumab (H) in Pts with Her2-Positive Early Breast Cancer (Her2+Ebc): Interim Analysis of the Open-Label, Randomised Cross-Over Phrancesca Study

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Patient (Pt) Preference and Satisfaction with the Subcutaneous Fixed-Dose Combination of Pertuzumab (P) and Trastuzumab (H) in Pts with Her2-Positive Early Breast Cancer (Her2+Ebc): Interim Analysis of the Open-Label, Randomised Cross-Over Phrancesca Study

Links Úteis

Ajuda